This football season, Americans want to watch sports, not Big Pharma ads.

But this fall, pharma companies spent millions on advertisements pushing their products.

What's worse?

Big Pharma increased spending even as lawmakers from both sides of the aisle tried to stop their misleading ads.

Enough is enough.

Big Pharma needs to lower drug prices, not spend more on ads that nobody wants.

Sponsored by the Pharmaceutical Reform Alliance, Inc.

Today on the Playbook podcast, Paul Ingracia is out as the nominee to lead the Office of Special Council following Politico's reporting on his past text messages.

We'll drill down into what else is worrying the White House today.

The NATO Secretary General Mark Rutter is in town on an emergency trip after Donald Trump's summit with Vladimir Putin got

cancelled and it is day 22 of the government shut down and we still don't see any movement.

Good morning. I'm Jack Blanchard. And I'm Megan Messerley. It's Wednesday, October 22nd.

Great to see you, Megan. Thanks for joining us. Great to see you, Jack, and this beautiful fall morning. It's Wednesday, October 22nd. Great to see you, Megan. Thanks for joining us.

Great to see you, Jack, and this beautiful fall morning. This beautiful fall morning, my beautiful

fall evening was rather blown up last night at exactly 6.56 p.m. when a character we've been

talking about on the podcast all week, Paul Ingracia finally withdrew his

nomination to lead the Office of Special Counsel. I'm guessing most people listening to this have read

the Politico story about Mr. Ingrisio on Monday by our excellent colleague, Daniel Lippmann.

If anyone's late to this story, let me just give you a quick run through on Monday, we reported

that Ingracier had made a number of offensive remarks in a text message chain.

He'd said he had a, quote, Nazi streak according to the messages.

And when he was discussing the human rights leader, Martin Luther King, Jr., he told the group in January 24,

...